What is the term for benign (non‑malignant) pleural disease in a patient with pleuritic chest pain and no red‑flag signs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Terminology for Benign Pleural Disease

The accepted medical term for benign (non-malignant) pleural disease is "non-malignant pleural effusion" (NMPE), though it is also commonly referred to as "benign pleural effusion." 1

Key Terminology and Context

The 2024 European Respiratory Society statement explicitly defines this terminology, noting that non-malignant pleural effusions (NMPEs) are also known as "benign" pleural effusions 1. However, the guidelines emphasize an important caveat: the term "benign" is somewhat misleading given the significant morbidity and mortality associated with these conditions.

Important Clinical Reality

Despite being labeled "benign," these effusions carry substantial mortality rates:

  • Heart failure-related effusions: 50% 1-year mortality
  • Renal failure-related effusions: 46% 1-year mortality
  • Liver failure-related effusions: 25% 1-year mortality

This renders the term "benign" a misnomer in many cases 1.

Specific Diagnostic Category: Nonspecific Pleuritis (NSP)

When pleural biopsy shows only inflammation and fibrosis without definitive features of malignancy, tuberculosis, or other specific diseases, the histological diagnosis is termed "nonspecific pleuritis" (NSP) 1. This occurs in up to 40% of pleural biopsies and represents a diagnostic challenge, as 8-12% of NSP cases eventually prove to be malignancy, particularly mesothelioma 1, 2.

Common Causes of NMPE Include:

  • Transudative effusions (heart failure, hepatic hydrothorax, end-stage renal failure)
  • Benign asbestos-related pleural effusion
  • Post-surgical effusion
  • Nonspecific pleuritis
  • Inflammatory conditions (rheumatoid arthritis, drug-induced)

1, 3

Epidemiological Significance

NMPEs are far more common than malignant effusions, with an estimated incidence of 252 per 100,000 population compared to the overall pleural effusion incidence of 337 per 100,000 1. These conditions account for approximately 75% of total healthcare resource allocation for pleural effusion management in the United States 1.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.